Literature DB >> 16493452

Determinants of vitamin D status in adult Crohn's disease patients, with particular emphasis on supplemental vitamin D use.

J Gilman1, F Shanahan, K D Cashman.   

Abstract

OBJECTIVE: To investigate determinants (pathophysiologic and physiologic, behavioural and lifestyle) of vitamin D status in Irish Crohn's disease (CD) patients.
DESIGN: A cross-sectional observational study.
SETTING: Cork City, Ireland (52 degrees N).
SUBJECTS: Crohn's Disease patients (n=58; mean age 38.1 years) were recruited from Cork University Hospital.
RESULTS: Fifty and nineteen percent of Irish CD patients were vitamin D deficient (defined by serum 25 hydroxyvitamin (OH) D levels <50 nmol/l) during winter and summer, respectively. Multiple regression analysis showed that summer-time serum 25 (OH) D levels were positively associated with use of vitamin D supplements (P=0.033) and negatively associated with smoking (P=0.006) and being male (P=0.063). During winter-time, use of vitamin D supplements (P=0.041) and sun habits (P=0.066) were positively associated, whereas small intestinal involvement (P=0.005) and body mass index (BMI) (P=0.083) were negatively associated with serum 25 (OH) D levels. There was no significant association between other non-pathophysiologic (age, dietary calcium or vitamin D) or pathophysiologic factors (steroid use, resection), and serum 25 (OH) D levels, at either season. Approximately 41 and 60% of the total variation in summer- and winter-time serum 25 (OH) D, respectively, was explained by this model.
CONCLUSION: A high proportion of Irish CD patents had some level of vitamin D deficiency (<50 nmol/l) during late-wintertime. Use of regular low-dose supplemental vitamin D, particularly by patients with small intestinal involvement, cessation of smoking and adequate, but responsible, exposure to summer sunlight as well as maintaining BMI in the normal range could help maintain adequate vitamin D levels during wintertime.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16493452     DOI: 10.1038/sj.ejcn.1602395

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  23 in total

1.  Use of exclusive enteral nutrition is just as effective as corticosteroids in newly diagnosed pediatric Crohn's disease.

Authors:  Jason Soo; Bushra A Malik; Justine M Turner; Rabin Persad; Eytan Wine; Kerry Siminoski; Hien Q Huynh
Journal:  Dig Dis Sci       Date:  2013-09-12       Impact factor: 3.199

2.  Vitamin D Status Is Associated with Intestinal Inflammation as Measured by Fecal Calprotectin in Crohn's Disease in Clinical Remission.

Authors:  Tara Raftery; Megan Merrick; Martin Healy; Nasir Mahmud; Colm O'Morain; Sinead Smith; Deirdre McNamara; Maria O'Sullivan
Journal:  Dig Dis Sci       Date:  2015-03-11       Impact factor: 3.199

3.  Higher vitamin D serum concentration increases health related quality of life in patients with inflammatory bowel diseases.

Authors:  Tibor Hlavaty; Anna Krajcovicova; Tomas Koller; Jozef Toth; Monika Nevidanska; Martin Huorka; Juraj Payer
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

Review 4.  The impact of smoking in Crohn's disease: no smoke without fire.

Authors:  Marian C Aldhous; J Satsangi
Journal:  Frontline Gastroenterol       Date:  2010-09-23

5.  Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis.

Authors:  Venu Lagishetty; Alexander V Misharin; Nancy Q Liu; Thomas S Lisse; Rene F Chun; Yi Ouyang; Sandra M McLachlan; John S Adams; Martin Hewison
Journal:  Endocrinology       Date:  2010-04-14       Impact factor: 4.736

6.  Factors associated with vitamin D deficiency in a multicultural inflammatory bowel disease cohort.

Authors:  Sukhdev Chatu; Vivek Chhaya; Rosamund Holmes; Penny Neild; Jin-Yong Kang; Richard C Pollok; Andrew Poullis
Journal:  Frontline Gastroenterol       Date:  2012-10-31

Review 7.  Review article: vitamin D and inflammatory bowel diseases.

Authors:  V P Mouli; A N Ananthakrishnan
Journal:  Aliment Pharmacol Ther       Date:  2013-11-17       Impact factor: 8.171

8.  Altered endocrine and autocrine metabolism of vitamin D in a mouse model of gastrointestinal inflammation.

Authors:  Nancy Liu; Lisa Nguyen; Rene F Chun; Venu Lagishetty; Songyang Ren; Shaoxing Wu; Bruce Hollis; Hector F DeLuca; John S Adams; Martin Hewison
Journal:  Endocrinology       Date:  2008-06-05       Impact factor: 4.736

9.  Normalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in Crohn's disease.

Authors:  Ashwin N Ananthakrishnan; Andrew Cagan; Vivian S Gainer; Tianxi Cai; Su-Chun Cheng; Guergana Savova; Pei Chen; Peter Szolovits; Zongqi Xia; Philip L De Jager; Stanley Y Shaw; Susanne Churchill; Elizabeth W Karlson; Isaac Kohane; Robert M Plenge; Shawn N Murphy; Katherine P Liao
Journal:  Inflamm Bowel Dis       Date:  2013-08       Impact factor: 5.325

Review 10.  Osteoporosis in inflammatory bowel disease.

Authors:  Tauseef Ali; David Lam; Michael S Bronze; Mary Beth Humphrey
Journal:  Am J Med       Date:  2009-07       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.